HALF-YEAR REPORT

April - Juni

2021

Presentation

CEO Håkan Lagerberg

CFO Jenny Graflind

Q2 2021 Highlights

Fast synergies and opening of veterinary clinics gave a record boost in Q2

Strong Growth +400% & organic growth +45%, improved profitability

Strong recovery in Vet & Pet channel

Strong growth in all markets and product groups - Several revenue records in group

New ProDen PlaqueOff® projects and online projects

Largest acquisition in company history -

Vetio

Integration and other Projects

  • Launch of Topicals/dermatology products in Pet Retail channel in USA
  • Production of dermatology products in Ireland getting closer
  • Move of Holden2 warehouse - larger, more effective with other group companies
  • Animal Pharm to Amazon and Chewy and Pet MD® on Amazon UK
  • Many bigger business opportunities discussed
  • Fantastic quarter from many group companies
  • Solved Brexit challenges, UK-EU
  • Online investments with excellent ROI

Key Performance Indicators

Q2 2021

Key Performance Indicators

H1 2021

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Swedencare AB published this content on 29 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2021 13:18:31 UTC.